Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2004
10/06/2004CN1169954C Coding of human protein polynucleotide able to suppress growth of cancer cells
10/06/2004CN1169835C Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/06/2004CN1169833C Human Protein with cancer inhibiting function and its coding sequence
10/06/2004CN1169832C Identification and function research of gene p28-II
10/06/2004CN1169831C Human protein with cancer call growth suppressing function and its coding sequence
10/05/2004US6800791 Method for delivery of proteins to plant cells
10/05/2004US6800768 Non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
10/05/2004US6800744 Useful as targets for detection/prevention of infections
10/05/2004US6800743 Pyrimidine derivatives for labeled binding partners
10/05/2004US6800732 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same
10/05/2004US6800728 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties
10/05/2004US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor
10/05/2004US6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
10/05/2004CA2463719A1 Nucleotide analogs with six membered rings
10/03/2004CA2461445A1 Multisignal labeling reagents, and processes and uses therefor
10/02/2004CA2423327A1 Single nucleotide polymorphisms for the diagnosis and treatment of schizophirenia spectrum disorders
10/01/2004WO2005038029A2 Luciferase biosensor
10/01/2004CA2541765A1 Luciferase biosensor
09/2004
09/30/2004WO2004083816A2 Loss of heterozygosity of the dna markers in the 12q22-23 region
09/30/2004WO2004083399A2 Aberrantly methylated genes in pancreatic cancer
09/30/2004WO2004083394A2 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders
09/30/2004WO2004083388A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
09/30/2004WO2004083386A2 Methods of making repetitive sequences removed probes and use thereof
09/30/2004WO2004083378A2 Mammalian cell lines specifically deficient in o-linked glycosylation
09/30/2004WO2004082640A2 Human serum albumin conjugates with therapeutic compounds
09/30/2004WO2004082370A2 Cardiac-preferred genetic alteration of transgenic rabbits
09/30/2004WO2004073603A3 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity
09/30/2004WO2004062478A9 Isolation and characterization of eca1, a gene overexpressed in endometrioid carcinomas of ovary and endometrium
09/30/2004WO2004052306A3 Modulation of ppar-alpha expression
09/30/2004WO2004038377A3 Method for diagnosing renal diseases or predispositions
09/30/2004WO2004035819A8 Oligonucleotide analogues for detecting and analyzing nucleic acids
09/30/2004WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
09/30/2004WO2003048332A3 METHODS FOR ANALYZING METHYLATED CpG ISLANDS AND GC RICH REGIONS
09/30/2004US20040192918 Controlling gene expression; antisense agents; nuclease resistance
09/30/2004US20040192893 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics
09/30/2004US20040192632 comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with the Non-Immunogenic or High Molecular Weight Compound
09/30/2004US20040192609 Peptides binding gp120 of HIV-1
09/30/2004US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/30/2004US20040191910 Genes encoding plant transcription factors
09/30/2004US20040191905 Modulation of HIV replication by RNA interference
09/30/2004US20040191887 Comprises nucleotide sequences coding synaptotagmin membrane proteins for diagnosis, treatment and prevention of botulinum neurotoxicity
09/30/2004US20040191873 Determining transcription profile for cell with simultaneous identification of intron/exon boundaries; functional genomics and transcriptomics
09/30/2004US20040191823 Universal e-tag primer and probe compositions and methods
09/30/2004US20040191822 Using restriction fragment length polymorphisms in cytochrome genes to screen for multidrug resistance; tools for monitoring allelic variation generated via exposue to fexofenadine and cyclosporine
09/30/2004US20040191815 Array having oligonucleotides on a metal substrate
09/30/2004US20040191808 Reagents for oligonucleotide cleavage and deprotection
09/30/2004US20040191796 8-(3-{[bis(methylethyl)amino](2-cyanoethoxy)phosphinooxy}propyl)- 7-oxophenoxazin-3-yl 2,2-dimethylpropanoate; improves signal to noise ratios and other advantageous characteristics in hybridization and related assays
09/30/2004US20040191782 Evaluating colon tumors for recurrence via differential gene expression of tumor antigen genes in bowel cell walls; cancer diagnosis and treatments; antitumor agents
09/30/2004US20040191776 Method for genotyping and quantifying Hepatitis B Virus
09/30/2004US20040191773 Oligoribonucleotides and ribonucleases for cleaving RNA
09/30/2004US20040191768 Process for typing of HCV isolates
09/30/2004DE10312625A1 Method for preparing functional peptide nucleic acids, useful e.g. in gene therapy and as detection probes, using protected synthon that allows subsequent reaction with functional carboxylic acid
09/30/2004CA2855229A1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
09/30/2004CA2519456A1 Aberrantly methylated genes in pancreatic cancer
09/30/2004CA2464894A1 Colorectal cancer prognostics
09/29/2004EP1462528A1 Nucleic acid immobilization and use as a biosensor
09/29/2004EP1461354A2 An isolated polynucleotide associated with type ii diabetes mellitus and methods of use thereof
09/29/2004EP1461353A2 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
09/29/2004EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes
09/29/2004EP1461052A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
09/29/2004EP1307595A4 Vhl promoter diagnostic polymorphism
09/29/2004EP0918877B1 Methods for isolating nucleic acids using alkaline protease
09/29/2004CN1533442A Cimeric immunomodulatory compounds and methods of using the same
09/29/2004CN1533437A DNA sequences for regulating transcription
09/29/2004CN1533433A Method for virus propagation
09/29/2004CN1532293A Nuclein acid fixing method and method for producing biosensor by said method
09/29/2004CN1532203A Method for separating single biological macro molecule
09/29/2004CN1532202A ANtisense oligonucleotides of targeting human cell death inhibiting protein family member survival protein mRNA, medicinal composition containing them and its use for treating cancer
09/29/2004CN1168836C Determination for specificity of candida albicans DNA sequence (3) and use thereof
09/29/2004CN1168835C Determination for specificity of Candida albicans DNA sequence (2) and use thereof
09/29/2004CN1168834C Determination for specificity of Candida albicans DNA sequence (5) and use thereof
09/29/2004CN1168833C Determination for specificity of candida albicans DNA sequence (4) and use thereof
09/29/2004CN1168831C Construction of recombinant human B lymphocyte stimulating factor expression vector, DNA immunopreparation of monoclonal antibody and use thereof
09/29/2004CN1168828C Carotenoid production by fermentation
09/29/2004CN1168827C Nucleotide specific to O-antigen of shigella boydii 7
09/29/2004CN1168826C Identifying probe and method for nucleotide sequence and nucleic acid molecule of red tide phaeocystis globosa
09/29/2004CN1168763C Process for continuously extracting corn protein, olgiose, saponin and nucleic acid from corn germs
09/29/2004CN1168737C Genosenoside biological synthesis relative gene
09/29/2004CN1168736C Composition and method for delivery of nucleic acids
09/28/2004US6797818 Methods for labeling nucleotides, labeled nucleotides and useful intermediates
09/28/2004US6797817 Nucleic acid fragments for the identification of dechlorinating bacteria
09/28/2004US6797510 Human kinases and polynucleotides encoding the same
09/28/2004US6797509 Dna sequences from coryneform bacteria which encode a protein having transaldolase activity; for the fermentative production of l-amino acids
09/28/2004US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
09/28/2004US6797475 Detection of polymorphisms in the human 5-lipoxygenase gene
09/28/2004US6797464 Detection of drug-resistant human immunodeficiency virus
09/25/2004CA2461828A1 Lung cancer detection
09/24/2004WO2005111058A1 Intracellular delivery of osteoinductive proteins and peptides
09/23/2004WO2004081574A2 Detection, monitoring and treatment of cancer
09/23/2004WO2004081520A2 Optically decodable microcarriers, arrays and methods
09/23/2004WO2004081226A2 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use
09/23/2004WO2004081224A2 Reca-assisted allele specific oligonucleotide extension method
09/23/2004WO2004081183A2 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
09/23/2004WO2004081177A2 Intracellular signaling pathways in diabetic subjects
09/23/2004WO2004081175A2 Methods and compositions for purification of nucleic acid from a host cell
09/23/2004WO2004081173A2 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
09/23/2004WO2004081032A2 Novel litaf binding site peptides and methods of using the same
09/23/2004WO2004081021A2 Oligonucleotide mimetics
09/23/2004WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
09/23/2004WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth